Unlearn.AI named to the 2021 CB Insights AI 100 List of Most Innovative Artificial Intelligence Startups

The AI 100 is CB Insights' annual list of the 100 most promising private AI companies in the world. This year’s winners are working on solutions including AI transparency, climate risk, virus modeling, and more.

CB Insights has unveiled the winners of the fifth annual AI 100. This year’s cohort of promising private AI companies represents 12 countries and is driving innovation across 18 industries and a broad range of cross-industry applications.

The products that this year’s winners are bringing to market — from drug R&D and revenue cycle management for hospitals to autonomous beekeeping and municipal waste sortation — highlight the breadth and depth of AI’s impact on industries.

Using the CB Insights platform, our research team picked these 100 private market vendors from a pool of over 6K companies, including applicants and nominees. They were chosen based on factors including business relations, investor profile, news sentiment analysis, R&D activity, proprietary Mosaic scores, market potential, competitive landscape, team strength, and tech novelty.

Enter your email address to download paper.

Click the link to begin download.
Oops! Something went wrong while submitting the form.

Enter your email address to watch the webinar.

Click the link to watch webinar.
Oops! Something went wrong while submitting the form.
Webinars

Part 3: Innovation in Clinical Research: AI-based Drug Development Tools and the Regulatory Landscape‍

Webinars

Part 2: Faster, More Efficient Trials: Novel Trial Designs using Digital Twins‍

Webinars

Part 1: AI, Digital Twins, and the Future of Clinical Research‍

Learn about how Digital Twins are created and how they are incorporated into clinical trials to increase power, accelerate timelines, and enable patient level insights.
Watch an overview of specific use cases for Digital Twins and learn how novel trial designs with Digital Twins enable smaller trials that maintain their power.
Watch a panel discussion on the regulatory landscape where experts share perspectives on the future of AI-based drug development tools like Digital Twins.